UBS analyst Joshua Spector downgrades Huntsman (NYSE:HUN) from Buy to Neutral.
Anavex Life Sciences Reports New Publication In Scientific Journal Demonstrating The Potential Of ANAVEX 3-71 To Prevent Cognitive Decline In Alzheimer’s Disease
ANAVEX®3-71 treatment prevents cognitive impairment, reduces amyloid, and neuroinflammation even after a long drug washout ANAVEX®3-71 halts neurodegeneration and prevents cognitive decline in a transgenic